Table 4.
Non- Randomised trials assessed according to MINORS criteria.
| MINORS criteria | Barman et al., 2019. | Kumar et al. | Barman et al., 2021 | Yadav et al. | |
|---|---|---|---|---|---|
| 1 | A clearly stated aim (0,1 or 2) | 2 | 2 | 2 | 2 |
| 2 | Inclusion of consecutive patients | 2 | 1 | 2 | 2 |
| 3 | Prospective collection of data | 2 | 2 | 2 | 2 |
| 4 | Endpoints appropriate to the aim of the study | 2 | 2 | 2 | 2 |
| 5 | Unbiased (blinded) assessment of the study endpoint | 2 | 0 | 2 | 0 |
| 6 | Follow-up period appropriate to the aim of the study | 2 | 2 | 2 | 2 |
| 7 | Loss to follow up less than 5 %: | 1 | 0 | 1 | 0 |
| 8 | Prospective calculation of the study size | 2 | 0 | 2 | 0 |
| 9 | An adequate control group | 2 | 2 | 2 | 2 |
| 10 | Contemporary groups: | 2 | 2 | 2 | 2 |
| 11 | Baseline equivalence of groups | 1 | 2 | 2 | 0 |
| 12 | Adequate statistical analyses | 2 | 0 | 2 | 0 |
| Total (20–24 high, 15–19 mod, <15 low) | 22 | 15 | 23 | 14 |
MINORS, methodological index for non-randomized studies.